Reproductive Medicine Center, The First Affiliated Hospital, Anhui Medical University, Hefei, China.
Metabolism. 2011 Nov;60(11):1511-4. doi: 10.1016/j.metabol.2010.10.006.
Polycystic ovary syndrome (PCOS) is one of the common defects that cause ovary dysfunction and link to the aberrant process of folliculogenesis. Bone morphogenetic protein 15 (BMP15) is expressed in human oocytes and functions importantly to regulate early follicle growth and fertility. Previous studies have discovered several mutations in the screening of BMP15 in premature ovarian failure but none in PCOS. In this current study, we focused on the mutational analysis of the coding region of BMP15 among 216 Chinese PCOS patients. Five novel missense mutations in BMP15 were discovered, namely, c.34C>G, c.109G>C, c.169C>G, c.288G>C, and c.598C>T. These results are the first to indicate that BMP15 gene mutations may be potentially associated with PCOS patients.
多囊卵巢综合征(PCOS)是引起卵巢功能障碍并与卵泡发生异常过程相关的常见缺陷之一。骨形态发生蛋白 15(BMP15)在人卵母细胞中表达,对调节早期卵泡生长和生育力具有重要作用。先前的研究在卵巢早衰的 BMP15 筛选中发现了几个突变,但在 PCOS 中没有发现。在本研究中,我们专注于 216 名中国 PCOS 患者中 BMP15 编码区的突变分析。发现了五个新的 BMP15 错义突变,即 c.34C>G、c.109G>C、c.169C>G、c.288G>C 和 c.598C>T。这些结果首次表明 BMP15 基因突变可能与 PCOS 患者有关。